S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
Free Trial
OTCMKTS:ENUM

(ENUM) (ENUM) Stock Price, News & Analysis

→ I’m officially sounding the alarm. (From Altimetry) (Ad)
Free ENUM Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0030
▼
$0.0036
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.19
Volume
242,116 shs
Average Volume
1.06 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ENUM stock logo

About (ENUM) Stock (OTCMKTS:ENUM)

Enumeral Biomedical Holdings, Inc., a biopharmaceutical company, engages in discovering and developing antibody immunotherapies that help the immune system fight cancer and other diseases. It is developing two antagonist PD-1 antibodies, such as ENUM 388D4 and ENUM 244C8 for use in treating cancer. The company is also developing antibody drug candidates for various immunomodulatory protein targets, including TIM-3, CD39, and TIGIT. Enumeral Biomedical Holdings, Inc. has collaboration agreements with Merck Sharp & Dohme Corp.; and The University of Texas MD Anderson Cancer Center, as well as a research contract with the National Cancer Institute. Enumeral Biomedical Holdings, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.

ENUM Stock News Headlines

December 27, 2021 | msn.com
How to add Safe Mode to the boot menu in Windows 11
August 28, 2021 | msn.com
Report: Coronavirus booster shots may be recommended after 6 months instead of 8
See More Headlines
Receive ENUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ENUM) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2017
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:ENUM
Previous Symbol
OTCBB:ENUM
CUSIP
N/A
CIK
1561551
Web
www.enumeral.com
Phone
617-945-9146
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

ENUM Stock Analysis - Frequently Asked Questions

How were (ENUM)'s earnings last quarter?

(ENUM) (OTCMKTS:ENUM) posted its quarterly earnings results on Monday, August, 14th. The company reported ($0.02) EPS for the quarter. The company earned $0.19 million during the quarter.

What other stocks do shareholders of (ENUM) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ENUM) investors own include CytoDyn (CYDY), Winthrop Realty Trust (FUR), Ebix (EBIX), Duke Energy (DUK), Walt Disney (DIS), Dollar General (DG), CÜR Media (CURM), Cree (CREE), Carnival Co. & (CCL) and Biogen (BIIB).

This page (OTCMKTS:ENUM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research